Journal profile · Transplantation

Experimental and Clinical Transplantation

ISSN 1304-0855 · eISSN 2146-8427 · Baskent University · TURKEY · Quarterly · Founded 2003

Experimental and Clinical Transplantation: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.65; subscription journal; review 6–12 weeks (community reports); community-reported acceptance: easy; 119 articles in 2025; indexed in SCIE and Scopus.

Impact factor0.65Latest value listed by LetPub
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review time6–12 weeksCommunity average
APC—No source gives fee information
AcceptanceEasyCommunity average
Articles per year1192025 · OpenAlex count

Scope

Aims, scope and focus

Experimental and Clinical Transplantation is published by Baskent University and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Renal Transplantation Outcomes and Treatments, Organ Transplantation Techniques and Outcomes and Organ Donation and Transplantation, together about 45.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

The scope of the journal includes the following: Surgical techniques, innovations, and novelties Immunobiology and immunosuppression Clinical results Complications

From the journal's Aims & Scope

Research area (LetPub): Transplantation

Editor-in-chief Mehmet HABERALPublisher website

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Renal Transplantation Outcomes and TreatmentsMedicine17.9%
  2. Organ Transplantation Techniques and OutcomesMedicine16.5%
  3. Organ Donation and TransplantationMedicine10.9%
  4. Liver Disease and TransplantationMedicine8.7%
  5. Renal and Vascular PathologiesMedicine6.8%
  6. Transplantation: Methods and OutcomesMedicine6.6%
  7. Cytomegalovirus and herpesvirus researchMedicine3.1%
  8. Polyomavirus and related diseasesMedicine3%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorTransplantationZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorTransplantationZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorTransplantationZone 4

Top journal: noReview journal: no

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

MEDLINEPubMedPublisher website

Other: EBSCO, Journal Citation Reports/Science Edition, Turkey Citation Index

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
0.65LetPub ·
CiteScore 2026-06
1.4LetPub ·
SJR 2026-06
0.25LetPub ·
SNIP 2026-06
0.36LetPub ·
h-index
25LetPub ·
h-index
30OpenAlex ·
i10-index
348OpenAlex ·
2-year mean citedness
0.78OpenAlex ·
Self-citation rate
14.3%LetPub ·
Share of gold OA articles
0.4%LetPub ·

Volume

Articles per year
125LetPub ·

Articles by year OpenAlex count · 2,844 in total · the current year is incomplete

YearArticlesOpen accessCitations
20261632151
2025119137
20242333212
20231634306
202222413701
202122610812

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
6–12 weeksLetPub ·
Average acceptance (community reports)
EasyLetPub ·

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Subscription journalLetPub

A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.

No source has fee information yet; check the journal's website.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare5 items from the author guidelines
Abstract
≤ 300 words
Keywords
3–5
Manuscript length
≤ 1,500 words
Reference style
AMA
Not considered
Supplemental materials
Publisher website · model-extracted, each line checked against the text
Policy excerpts from the journal's websitePublication ethics
Publication ethics

Ethics policy requiring ethics committee review and compliance with Helsinki Declaration and Declaration of Istanbul. Model summary

The Journal expects that all procedures and studies involving human subjects have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in The Helsinki Declaration as well as The Declaration of Istanbul on Organ Trafficking and Transplant Tourism.

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Baskent University
Country or region
TURKEY
Language
English
Frequency
Quarterly
Founded
2003
ISSN
1304-0855
Electronic ISSN
2146-8427
Society / sponsor
Middle East Society for Organ Transplantation
Official links

FAQ

Frequently asked questions about Experimental and Clinical Transplantation

What CAS zone is Experimental and Clinical Transplantation in?

In the 2025 upgraded edition of the CAS Journal Ranking, Experimental and Clinical Transplantation is in Zone 4 of Medicine, and in Zone 4 of the minor category Transplantation. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Experimental and Clinical Transplantation?

The latest impact factor listed by LetPub is 0.65; CiteScore 1.4, h-index 30.

How long does peer review take at Experimental and Clinical Transplantation?

Authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of Experimental and Clinical Transplantation?

According to the journal's author guidelines: Abstract: ≤ 300 words; Keywords: 3–5; Manuscript length: ≤ 1,500 words; Reference style: AMA. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Which databases index Experimental and Clinical Transplantation?

According to LetPub and DOAJ records, Experimental and Clinical Transplantation is indexed in SCIE and Scopus. The journal's website also lists MEDLINE and PubMed; that list has not been checked against each database.

Is Experimental and Clinical Transplantation open access, and what is the APC?

Experimental and Clinical Transplantation is a subscription journal. Fee information is not available yet; check the journal's website.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .